Home ARVN
41.39
  Price4.13%   +1.64
 
loading

Arvinas Inc (ARVN) Latest News

Nov-23-22 10:56AM Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%Benzinga
08:58AM Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The BoxBenzinga
Nov-23-22 08:06AM Analyst Ratings for ArvinasBenzinga
07:06AM Where Arvinas Stands With AnalystsBenzinga
Nov-23-22 06:54AM Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For AutodeskBenzinga
Nov-22-22 07:12AM Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)GlobeNewswire Inc.
05:21AM Carvana, Crocs And Other Big Losers From MondayBenzinga
Nov-22-22 03:49AM Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From YesterdayBenzinga
Nov-21-22 01:36AM Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day SessionBenzinga
Nov-08-22 08:15AM Arvinas, Inc. (ARVN) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research
Nov-01-22 08:32AM Why Arvinas (ARVN) Might Surprise This Earnings SeasonZacks Investment Research
Oct-27-22 11:04AM Strength Seen in Arvinas, Inc. (ARVN): Can Its 12% Jump Turn into More Strength?Zacks Investment Research
02:39AM Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From YesterdayBenzinga
Oct-26-22 12:35PM Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day SessionBenzinga
10:45AM Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On WednesdayBenzinga
Sep-30-22 09:00AM Arvinas Gives Back to Local Greater New Haven CommunityGlobeNewswire Inc.
Sep-09-22 11:11AM Where Arvinas Stands With AnalystsBenzinga
10:40AM Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022Benzinga
Sep-09-22 09:27AM Expert Ratings for ArvinasBenzinga
Aug-18-22 08:55AM Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This StockBenzinga
04:59AM This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From YesterdayBenzinga
Aug-17-22 01:04AM Sanofi, Children's Place And Some Other Big Stocks Moving Lower On WednesdayBenzinga
12:03PM Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day SessionBenzinga
Aug-15-22 07:00AM Arvinas Appoints Lisa Sinclair as Senior Vice President, Corporate OperationsGlobeNewswire Inc.
Aug-08-22 09:19AM 8 Analysts Have This to Say About ArvinasBenzinga
Aug-04-22 08:35AM Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research
Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.
Cap:    |  Volume (24h):